LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated...( LegalView re...),Health

LegalView recently reported on the risk of bone fractures among patients using proton pump inhibitor (PPI) drugs. The drugs are used to treat and reduce gastric acid within the stomach as well as other stomach/intestinal issues including ulcers, gastroesophageal reflux disease (GERD), dyspepsia, some forms of stomach infections and Zollinger-Ellison Syndrome.

Denver, CO (PRWEB) September 8, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, recently alerted patients taking http://proton-pump-inhibitors-ppi.legalview.com [proton pump inhibitor __title__ Proton Pump Inhibitor Risks] (PPI) drugs of the potential for serious bone fracture risks associated with taking the medication. A study published in a recent issue of the Canadian Medical Association Journal found that patients using PPIs for continued use (5 to 7 years or more) are at an increased risk of developing hip, spinal or wrist fractures. According to the study, patients at the most risk include those of 50 years of age or older.

Individuals who are currently prescribed to any of the http://proton-pump-inhibitors-ppi.legalview.com [proton pump inhibitors __title__ Proton Pump Inhibitor Lawsuit] such as pantoprazole, rabeprazole, esomeprazole, lansoprazole and omeprazole are encouraged to contact an experienced pharmaceutical lawyer to better understand how to develop a potential http://proton-pump-inhibitors-ppi.legalview.com [PPI __title__ Proton Pump Inhibitor Lawsuit] lawsuit. Several of the PPIs are more commonly known under their brand names including Losec, Prilosec, Inhibitol, Somac, Protonix, Pantoloc, Rabecid and Aciphex.

PPIs are used to in
'/>"/>